Literature DB >> 26617406

It is time to beelieve the CD1a hype!

Sai Harsha Krovi1, Laurent Gapin1.   

Abstract

Conventional T cells have historically been linked to exacerbating allergy. By efficiently generating primarily TH 2 cells, allergens skew the immune response to produce IL-4, IL-13, and IgE. Previously, CD1a-responsive T cells were shown to functionally respond to bee and wasp venom allergens. In this issue of the European Journal of Immunology, Subramaniam et al. [Eur. J. Immunol. 2016. 46: 242-252] show that more functionally active CD1a-restricted cells are present in bee venom-allergic patients than in healthy patients. Additionally, the authors show that these cells are not as frequently found in individuals receiving venom immunotherapy. Consequently, this study implicates CD1a-reactive cells as the primary responders to venom allergy, which considerably regulate the downstream immune response.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CD1a; Immunotherapy; T cell; Venom allergy

Mesh:

Substances:

Year:  2016        PMID: 26617406      PMCID: PMC4758348          DOI: 10.1002/eji.201546157

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  27 in total

1.  Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile.

Authors:  D Jankovic; M C Kullberg; N Noben-Trauth; P Caspar; W E Paul; A Sher
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

Review 2.  Bee venom allergy in beekeepers and their family members.

Authors:  Ulrich R Müller
Journal:  Curr Opin Allergy Clin Immunol       Date:  2005-08

Review 3.  Check MAIT.

Authors:  Laurent Gapin
Journal:  J Immunol       Date:  2014-05-15       Impact factor: 5.422

4.  The frequency and clinical significance of specific IgE to both wasp (Vespula) and honey-bee (Apis) venoms in the same patient.

Authors:  W Egner; C Ward; D L Brown; P W Ewan
Journal:  Clin Exp Allergy       Date:  1998-01       Impact factor: 5.018

5.  Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.

Authors:  C A Akdis; M Akdis; T Blesken; D Wymann; S S Alkan; U Müller; K Blaser
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

Review 6.  CD1: antigen presentation and T cell function.

Authors:  Manfred Brigl; Michael B Brenner
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

7.  Bee venom processes human skin lipids for presentation by CD1a.

Authors:  Elvire A Bourgeois; Sumithra Subramaniam; Tan-Yun Cheng; Annemieke De Jong; Emilie Layre; Dalam Ly; Maryam Salimi; Annaliza Legaspi; Robert L Modlin; Mariolina Salio; Vincenzo Cerundolo; D Branch Moody; Graham Ogg
Journal:  J Exp Med       Date:  2015-01-12       Impact factor: 14.307

8.  Elevated and cross-responsive CD1a-reactive T cells in bee and wasp venom allergic individuals.

Authors:  Sumithra Subramaniam; Aamir Aslam; Siraj A Misbah; Mariolina Salio; Vincenzo Cerundolo; D Branch Moody; Graham Ogg
Journal:  Eur J Immunol       Date:  2015-11-17       Impact factor: 5.532

9.  Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals.

Authors:  H Secrist; C J Chelen; Y Wen; J D Marshall; D T Umetsu
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

10.  Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells.

Authors:  Mübeccel Akdis; Johan Verhagen; Alison Taylor; Fariba Karamloo; Christian Karagiannidis; Reto Crameri; Sarah Thunberg; Günnur Deniz; Rudolf Valenta; Helmut Fiebig; Christian Kegel; Rainer Disch; Carsten B Schmidt-Weber; Kurt Blaser; Cezmi A Akdis
Journal:  J Exp Med       Date:  2004-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.